CD9 and cancer: Antibodies against CD9 and CD63, which are enriched on EVs, were administrated to human breast cancer xenograft mouse models, and circulating administrated EVs tagged by anti-CD9 and -CD63 were internalized by macrophages through phagocytosis, resulting in the inhibition of cancer progression [75].